David Berk, MD
Arcutis Biotherapeutics
4
0
3
N/A
0
7
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
David Berk, MD
Arcutis Biotherapeutics, Inc.
Shared therapeutic areas:
Worked with same sponsors:
Michael B Gill
Power Life Sciences Inc.
Shared therapeutic areas:
Gail Gauvreau, PhD
McMaster University
Shared therapeutic areas:
Robert Bissonnette, MD
Innovaderm Research Inc.
Shared therapeutic areas:
Amy Paller, MD
Northwestern University
Shared therapeutic areas:
jianzhong zhang
Peking University People's Hospital
Shared therapeutic areas:
Xinghua Gao
First Hospital of China Medical University
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Peter Aaby, DMSc
Bandim Health Project
Shared therapeutic areas:
Peter Wolf, MD
Medical University of Graz
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis
Safety and Efficacy of ARQ-154 Foam in Adolescent and Adult Subjects With Scalp and Body Psoriasis
Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis
All 4 trials loaded